Blistex Triple Essentials (Blistex Inc)


Welcome to the PulseAid listing for the Blistex Triple Essentials drug offered from Blistex Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Blistex Inc
NON-PROPRIETARY NAME: Octinoxate, Octisalate, and Dimethicone
SUBSTANCE NAME: OCTINOXATE; OCTISALATE; DIMETHICONE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: STICK
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2017-07-01
END MARKETING DATE: 0000-00-00


Blistex Triple Essentials HUMAN OTC DRUG Details:

Item DescriptionBlistex Triple Essentials from Blistex Inc
LABELER NAME: Blistex Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 6.6; 4.4; 2(g/100g; g/100g; g/100g)
START MARKETING DATE: 2017-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10157-1118_dcca2199-d178-4c5e-b815-f1cac798f776
PRODUCT NDC: 10157-1118
APPLICATION NUMBER: part347

Other OCTINOXATE; OCTISALATE; DIMETHICONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Blistex IncBlistex Triple Essentials